retatrutide hfpef trial just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Phase 2 Trial of Retatrutide

The extracts in it are based on some research, but marketing it as an alternative to actual GLP-1 injections would be my concern. She added that supplements will never achieve what prescription drugs can, based on strength alone

The main differences in injection technique depend on whether the medication comes in a pen, a syringe, or an autoinjector

Calcium release from the sarcoplasmic reticulum increases, making each contraction stronger

PLoS ONE 13 , e0196233 (2018)

As the dose increases, appetite suppression intensifies, but metabolic benefits from receptor engagement may already be near-maximal at intermediate dosing levels

Vaziri ND, Wang XQ, Oveisi F, Rad B